Effect of KCI Continus Tablet(K-Contin(R)) on Serum K and Uric Acid Level during Hydrochlorotihiazide Therapy.
10.4070/kcj.1985.15.3.413
- Author:
Jung Don SEO
;
Wang Sung RYU
;
Byung Hee OH
;
Young Woo LEE
- Publication Type:Original Article
- MeSH:
Dyspepsia;
Humans;
Hydrochlorothiazide;
Hypokalemia;
Potassium;
Uric Acid*
- From:Korean Circulation Journal
1985;15(3):413-419
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The effects of KCI continus tablet(K-Contin(R)) on the serum level of K and uric acid during hydrochlorothizide therapy(25mg/day) were evaluated in 30 patients with essential hypertensien. The results are as follows : 1) During hydrochlorothiazide therapy(25mg/day), 23% of all patients showed hypopotassemia(<3.5mEq/1) while no patient developed hypopotassemia after potassium supplement therapy(8 mEq/day). 2) During the period of K supplement, the level of serum uric acid showed less elevation. 3) The side reaction of KCI continus tablet were mild indigestion which developed in two patients and disappeared soon without any particular treatment. In conclusion, the KCI continus tablet is useful in the prevention of hypopotassemia during chronic diuretic therapy.
